Long Term Study With B2036-PEG

Status:
Completed

Trial end date:
2007-07-01

Target enrollment:

Participant gender:

Primary objective: To investigate the efficacy and safety of Pegvisomant in Japanese patients with acromegaly.

Phase 3

Pfizer